Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-03-19 | Amended | $2,392,270 | $2,342,270 | Other | 06b | SEC link |
| 2020-01-22 | New | $50,000 | $50,000 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Daniel Lunz | Director, Executive |
| Stephen Meltzer | Director |
| John Neiderhuber | Director |
| William Stevens | Executive |